Monday, 16 November 2026
Psychosis risk with ADHD stimulants, Functional fixed foot dystonia, Robots’ remaining limitations
- 01
Psychosis risk remains low with prescribed ADHD stimulants
Psychosis appears uncommon among people taking prescribed ADHD stimulants after appropriate assessment and monitoring, according to an analysis in The Conversation. Government-subsidised ADHD medicine dispensing rose from two per 1,000 Australians in 2004–05 to 22 per 1,000 in 2023–24, when stimulants accounted for 87% of prescriptions. Research combining 16 studies involving 390,000 people with ADHD found psychotic symptoms in 2.8% of those prescribed stimulants, while some studies found no association. Two population-based studies found psychosis was about twice as common with amphetamines as with methylphenidate, although ADHD itself may confer a higher risk irrespective of medication. The risk of harm, including psychosis, was considered higher with non-prescribed or illicit stimulant use.
- 02
Functional fixed dystonia of the foot noted in NEJM
An ahead-of-print item in the New England Journal of Medicine is titled “Functional Fixed Dystonia of the Foot”. The source provides no clinical details, findings or information about the patients affected. Further faithful summary is not possible from the limited text supplied.
via NEJM
- 03
No clinical details available on robots’ remaining limitations
No clinical or research findings were provided about what robots still cannot do. The source identifies only an ahead-of-print item in the New England Journal of Medicine, so further detail cannot be summarised.
via NEJM
- 04
Outpatient preceptor incentives questioned in ahead-of-print article
An ahead-of-print New England Journal of Medicine article concerns incentives for outpatient clinical preceptors. The source provides no article content beyond its title and publication status, so its arguments, evidence and affected settings cannot be summarised. Further detail is not available in the supplied text.
via NEJM
- 05
NEJM lists health policy research article ahead of print
The New England Journal of Medicine has listed an ahead-of-print article titled “Reimagining Health Policy Research”. The supplied source provides no abstract, findings or other article content. It therefore gives insufficient detail to describe the position being advanced, who it affects or its clinical significance.
via NEJM
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.